Chemours Co-The

Chemours Co-The Stock Forecast & Price Prediction

Live Chemours Co-The Stock (CC) Price
$21.74

9

Ratings

  • Buy 3
  • Hold 6
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$21.74

P/E Ratio

43.48

Volume Traded Today

$708,400

Dividend

$0.25

52 Week High/low

32.70/15.10

Chemours Co-The Market Cap

$3.26B

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $CC ๐Ÿ›‘

Before you buy CC you'll want to see this list of ten stocks that have huge potential. Want to see if CC made the cut? Enter your email below

CC Summary

Based on ratings from 9 stock analysts, the Chemours Co-The stock price is expected to increase by 9.37% in 12 months. This is calculated by using the average 12-month stock price forecast for Chemours Co-The. The lowest target is $18 and the highest is $32. Please note analyst price targets are not guaranteed and could be missed completely.

CC Analyst Ratings

Chemours Co-The has a total of 9 Wall St Analyst ratings. There are 3 buy ratings, 6 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Chemours Co-The will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.

CC stock forecast by analyst

These are the latest 20 analyst ratings of CC.

Analyst/Firm

Rating

Price Target

Change

Date

Arun Viswanathan
RBC Capital

Outperform

$25

Maintains

Nov 6, 2024
Michael Leithead
Barclays

Equal-Weight

$23

Maintains

Nov 5, 2024
Vincent Andrews
Morgan Stanley

Equal-Weight

$25

Maintains

Nov 5, 2024
Arun Viswanathan
RBC Capital

Outperform

$28

Maintains

Oct 11, 2024
John McNulty
BMO Capital

Outperform

$32

Maintains

Oct 7, 2024
Michael Leithead
Barclays

Equal-Weight

$21

Maintains

Sep 25, 2024
Duffy Fischer
Goldman Sachs

Neutral

$23

Maintains

Sep 3, 2024
Jeffrey Zekauskas
JP Morgan

Neutral

$18

Maintains

Aug 6, 2024
Michael Leithead
Barclays

Equal-Weight

$22

Maintains

Aug 6, 2024
John McNulty
BMO Capital

Outperform

$30

Maintains

Aug 6, 2024
Joshua Spector
UBS

Buy

$28

Maintains

Aug 6, 2024
Joshua Spector
UBS

Buy

$30

Upgrade

Jul 9, 2024
John Roberts
Mizuho

Neutral

$25

Initiates

Jun 7, 2024
John McNulty
BMO Capital

Outperform

$34

Upgrade

Apr 9, 2024
Joshua Spector
UBS

Neutral

$28

Maintains

Apr 2, 2024
Michael Leithead
Barclays

Equal-Weight

$30

Maintains

Apr 2, 2024
Joshua Spector
UBS

Neutral

$21

Downgrade

Mar 5, 2024
John McNulty
BMO Capital

Underperform

$19

Downgrade

Mar 1, 2024
John McNulty
BMO Capital

Underperform

$19

Downgrade

Feb 29, 2024
Arun Viswanathan
RBC Capital

Outperform

$40

Upgrade

Dec 1, 2023

CC Company Information

What They Do: Provides performance chemicals across multiple sectors.

Business Model: The company operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, generating revenue by selling a diverse range of chemical products including titanium dioxide, refrigerants, and industrial resins. These products are marketed via direct sales, indirect channels, and a network of resellers and distributors.

Other Information: Incorporated in 2014 and headquartered in Wilmington, Delaware, the company serves various industries including construction, packaging, electronics, and energy, positioning itself as a key player in the global chemicals market.
CC
Chemours Co-The (CC)

When did it IPO

2015

Staff Count

6,200

Country

United States

Sector/Industry

Basic Materials/Specialty Chemicals

CEO

Ms. Denise M. Dignam

Market Cap

$3.26B

Chemours Co-The (CC) Financial Data

In 2023, CC generated $6.03B in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that CC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

N/A

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year

Revenue From 2023

$6.03B

0.00 %
From Previous Year
  • Revenue TTM $5.75B
  • Operating Margin TTM 9.9%
  • Gross profit TTM $1.31B
  • Return on assets TTM 4.0%
  • Return on equity TTM 11.0%
  • Profit Margin 1.3%
  • Book Value Per Share 4.40%
  • Market capitalisation $3.26B
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • Revenue for 2023 $6.03B
  • EPS this year (TTM) $0.50

Chemours Co-The (CC) Latest News

News Image

Wed, 27 Nov 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Chemours Company completed a private offering of $600 million in 8.000% senior unsecured notes, maturing in 2033.

Why It Matters - The Chemours Company's $600 million bond offering at 8% indicates strong capital needs and might impact leverage and cash flow, influencing credit ratings and stock performance.

News Image

Thu, 21 Nov 2024

Sentiment - POSITIVE

Source - Seeking Alpha

Summary - Chemours Company has underperformed in 2024 with a 36% YTD decline. Despite seasonal challenges, its Thermal & Specialized Solutions division is driving growth, supported by regulatory tailwinds.

Why It Matters - Chemours' underperformance raises concerns, but growth in its profitable division and regulatory support may signal a potential turnaround, influencing investment decisions.

News Image

Wed, 13 Nov 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Chemours Company is conducting a private offering of $600 million in senior notes due in 2033.

Why It Matters - The Chemours Company's $600 million senior notes offering signals its capital-raising efforts, impacting debt levels, liquidity, and future growth potential, influencing investor sentiment.

News Image

Wed, 13 Nov 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Chemours Company has priced a private offering of $600 million in 8.000% senior notes maturing in 2033.

Why It Matters - Chemoursโ€™ $600M senior notes offering indicates strong financing strategy, potentially impacting liquidity and debt levels, influencing credit ratings and investment appeal.

News Image

Mon, 11 Nov 2024

Sentiment - POSITIVE

Source - Benzinga

Summary - Investors often seek dividend-yielding stocks during market turbulence, focusing on companies with strong free cash flows and high dividend payouts.

Why It Matters - Dividend-yielding stocks attract investors during market volatility, offering stability and income through high payouts, reflecting strong cash flows and potentially reducing portfolio risk.

News Image

Mon, 04 Nov 2024

Sentiment - NEUTRAL

Source - Seeking Alpha

Summary - Chemours (NYSE: CC) held its Q3 2024 earnings call on November 4, 2024, featuring CEO Denise Dignam and CFO Shane Hostetter, with participation from major financial analysts.

Why It Matters - The Chemours Q3 2024 earnings call provides insights into the company's financial health and future outlook, influencing stock performance and investor sentiment.

...

CC Frequently asked questions

The highest forecasted price for CC is $32 from John McNulty at BMO Capital.

The lowest forecasted price for CC is $18 from from Susquehanna

The CC analyst ratings consensus are 3 buy ratings, 6 hold ratings, and 0 sell ratings.